⌘K

Login Start Free

Home/Filings/4/0001213900-17-001492

4//SEC Filing

ORAMED PHARMACEUTICALS INC. 4

Accession 0001213900-17-001492

$ORMPCIK 0001176309operating

View on SEC.gov Company Profile

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 3:47 PM ET

Size

5.4 KB

Accession

0001213900-17-001492

Insider Transaction Report

Form 4

Period: 2017-02-09

ORAMED PHARMACEUTICALS INC.ORMP

Slager David Mark

10% Owner

Transactions

Award
Stock Option (right to buy)
2017-02-09+5,697→ 5,697 total
Exercise: $6.23Exp: 2027-02-09→ Common Stock (5,697 underlying)

Footnotes (1)

[F1]The Stock Option will vest immediately.

Documents

1 file

4
f4020917slager_oramed.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001176309

Filing Metadata

Form type: 4
Filed: Feb 15, 7:00 PM ET
Accepted: Feb 16, 3:47 PM ET
Size: 5.4 KB

View on SEC.gov